Skip to content

IDEXX LABORATORIES

Active
Private limited companyfounded 2006active for 20 yearsEsplanade 1, 1020 Brussel, Belgium213 active companies are registered at this addressKBO/BCE: BE 0882.866.482
Summary

IDEXX LABORATORIES has been active since 2006 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €49.3m and a net result of €733,180. Equity remains stable across the filed financial years (±1.4% per year). Its solvency ranks better than 93% of 46 sector peers (NACE 75, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Activity
Veterinary services
NACE 75000Other technical testing and analysis NACE 71209
Largest company by total assets in Belgium, Veterinary activities sector1 site
Size
€19.6mturnover 2025
Staff
17.2 FTE
Equity
€49.3m
Profit
€733,180
Financial health
95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Structure
Parent
IDEXX Laboratories Inc
Board
4 members
Auditor: BDO Bedrijfsrevisoren bvAccounts 31 days early
Why 95raises riskLiquidity: current ratio 30.77lowers riskSize: turnover €19.6m, 17.2 FTE, total assets €51.1mEquity €49.3m (96.5% of total assets)Sector: Veterinary activities (NACE 75)Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 67% of its sector peers (NACE 75, small)
Financial strength · tick = 2024
Strong
Solvency 100=
equity 96.5% of total assets
Liquidity 100=
short-term debt 3.2%
Profitability 31-9
return on assets 1.4%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (35 companies, NACE 75, small)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026lowest value 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026highest value 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026
Credit of up to €1,950,000 on 30-day terms is acceptable
Liquidity ample (current ratio 30.77, compared with 42.54 in 2024, above the usual 1.5; short-term debt: 3.2% of total assets), and 3.5% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 75, small): better than 93% on solvency, 99% on liquidity, 17% on profitability and 59% on growth.

The bankruptcy probability was computed on 12-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
raises risk · Liquidity: current ratio 30.77
NBB · annual accounts
lowers risk · Size: turnover €19.6m, 17.2 FTE, total assets €51.1m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Equity €49.3m (96.5% of total assets)
NBB · annual accounts
lowers risk · Sector: Veterinary activities (NACE 75)
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
31 days early
2024
42 days early
2023
21 days early
2022
41 days early
2021
40 days early
2020
29 days early
2019
29 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 33 days before the deadline; the sector median (NACE 75) for financial year 2024 is 6 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 21 June (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
13-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Resignation: Willard R. Blanche Jr. (director)Power of attorney
  2. Annual accounts filedfinancial year 2025 · full…
  3. Permanent representatives: Guillaume Rosolen and Manuel…Gazette deed

Key points

  • Positive: Largest company by total assets in Belgium, Veterinary activities sectorin the Checked rankings No. 1 View
  • Positive: 7 years of growth in a rowturnover 2025: €19.6m 7 years View
  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Controlled by IDEXX Laboratories Inc parent View
  • Caution: Result fell in 2025from €1.1m to €733,180 ▼ 36.1% View
  • A director leftlatest change 11-08-2026 · 4 in office 1 left View

By topic

Financials

Financial year
2025
Turnover
€19.6m
Profit
€733,180
Solvency
96.5%
Turnover▲ 12.8%
Net result
20182025
Go to Financials

Board & ownership

Board
4 members
Parent
IDEXX Laboratories Inc
Auditor
BDO Bedrijfsrevisoren bv
  • Geoffrey Scott BaurDirector
  • BLANCHE JR WillardDirector
  • CHADBOURNE JefferyDirector
  • Lily Joann LuDirector
Go to Board & ownership

Timeline

Events
43
Since
2006
Next accounts
by 31-07-2027
  1. 19-06-2025Annual accounts filed
  2. 13-05-2025Appointment: BDO Bedrijfsrevisoren BV (statutory auditor)
  3. 10-07-2024Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Veterinary servicesNACE 75000
Founded
04-08-2006
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
1
Purpose
“La Société a pour objet social, tant en Belgique qu'à l'étranger, pour son propre compte…” (deed in French)
Go to Articles of association

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.